Optano, a leading provider of AI-powered operations solutions, acquired by A.T. Kearney
The private shareholders of Optano GmbH have sold the company to A.T. Kearney. Optano will support them on operation engagements, chiefly in AI-powered supply chain projects, and large-scale operation transformations.
Optano is a leading provider of AI-powered operation optimization solutions for the automotive, chemical, consumer goods, logistics, energy and mining industries. The company’s software uses predictive and prescriptive analytics to offer end-to-end network, employee capacity logistics, network, production and supply chain planning. The solutions enable planning optimization and concrete recommendations for action.
Founded in 1926, A.T. Kearney is a leading global management consulting firm with more than 4,200 employees working in more than 40 countries. The company works closely together with its clients to find business solutions worldwide.
Oaklins’ team in Germany acted as the exclusive financial advisor to the sellers in this transaction.
Talk to the deal team
Related deals
Niscon Inc. has been acquired by SGPS ShowRig
Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.
Learn moreFairfest Media has acquired WTE Miami
Fairfest Media, organizer of OTM, the leading travel show in Asia, has acquired WTE Miami, the fastest-growing travel trade show in the USA. The acquisition marks a significant milestone in Fairfest’s global expansion, strengthening its presence in the Americas and beyond by leveraging decades of experience and leadership in Asia and India.
Learn moreBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Learn more